Role of the Stress in the Development of the Metabolic Syndrome

Role of Anxiety, Depression, Quality of Life and Stressful Vital Events in the Development of the Metabolic Syndrome. StreX Project.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01538082

Acronym

STREX

Enrollment

738

Registered

2012-02-23

Start date

2008-12-31

Completion date

2013-03-31

Last updated

2012-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders, Depressive Disorders, Metabolic Syndrome, Stress Disorders

Keywords

Anxiety disorders, Depressive disorders, Metabolic syndrome, Stress disorders, Primary care

Brief summary

The purpose of this study is determine the incidence of metabolic syndrome (MetS) in people of high risk, of 40 or more years and attended in the Primary Care. Evaluating the association between anxiety, depression, quality of life and the vital stressful events, and the development of the metabolic syndrome in general population. Our hypothesis is that population of the cohort with bigger degree of stress will develop earlier the metabolic syndrome. If our hypothesis about the metabolic syndrome are demonstrated, it would allow establishing in a future interventions on these factors of risk to prevent or to decrease the incidence of this syndrome in the Primary Care.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

40 Years to No maximum

Healthy volunteers

Inclusion criteria

* Both genders, elderly than 40 years * Subjects with 1 or 2 criteria of NCEP-ATPIII set for Metabolic Syndrome * Abdominal waist \> 102 cm ( men ) or \>88 cm ( women ) * Blood Pressure ( \>130/85 mmHg ) ( or else pharmacologic treatment of hypertension ) * Hypertriglyceridaemia ( \>150 mg/dl ) ( or else pharmacologic treatment ) * HDL-cholesterol \<40 mg/dl ( men ) or \<50 mg/dl ( women ) ( or else treatment ) * Fasting glucose \> 110 mg/dl.

Exclusion criteria

* Metabolic Syndrome (NCEP-ATPIII defined)(3 criteria of above mentioned) * Severe or terminal disease * Severe mental disease that difficulties the follow-up

Design outcomes

Primary

Measure	Time frame	Description
Incidence of metabolic syndrome	One year	Determining the incidence of metabolic syndrome ( MetS ) in people of high risk, older than 40 years and attended in the Primary Care.

Secondary

Measure	Time frame	Description
Association between risk factors and metabolic syndrome	One year	Association between anxiety, the depression, the quality of life and the vital stressful events and the metabolic syndrome

Countries

Spain

Contacts

Primary ContactCecilia Borau

cborau@idiapjgol.org934824124

Outcome results